» Authors » Tiina Tasmuth

Tiina Tasmuth

Explore the profile of Tiina Tasmuth including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 13
Citations 274
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Nurmi A, Pelttari L, Kiiski J, Khan S, Nurmikolu M, Suvanto M, et al.
Sci Rep . 2023 Nov; 13(1):21127. PMID: 38036545
In search of novel breast cancer (BC) risk variants, we performed a whole-exome sequencing and variant analysis of 69 Finnish BC patients as well as analysed loss-of-function variants identified in...
2.
Wendt C, Muranen T, Mielikainen L, Thutkawkorapin J, Blomqvist C, Jiao X, et al.
Sci Rep . 2021 Jul; 11(1):14763. PMID: 34285278
The risk of breast cancer associated with CHEK2:c.1100delC is 2-threefold but higher in carriers with a family history of breast cancer than without, suggesting that other genetic loci in combination...
3.
Sipila R, Hintsa T, Lipsanen J, Tasmuth T, Estlander A, Kalso E
Psychooncology . 2019 Jul; 28(10):2002-2008. PMID: 31325347
Objective: Anger, depressive symptoms, and anxiety are known reactions to cancer and suggested to modulate pain experience. We examined the association between anger regulation, mood, and pain in 952 breast...
4.
Kokkonen K, Tasmuth T, Lehto J, Kautiainen H, Elme A, Jaaskelainen A, et al.
Anticancer Res . 2018 Dec; 39(1):271-277. PMID: 30591468
Background/aim: To observe changes in symptoms and health-related quality of life (HRQoL) over 7 years among cancer patients at different stages of the disease. Patients And Methods: This prospective cross-sectional...
5.
Lotsch J, Sipila R, Tasmuth T, Kringel D, Estlander A, Meretoja T, et al.
Breast Cancer Res Treat . 2018 Jun; 171(2):399-411. PMID: 29876695
Background: Prevention of persistent pain following breast cancer surgery, via early identification of patients at high risk, is a clinical need. Supervised machine-learning was used to identify parameters that predict...
6.
Meretoja T, Leidenius M, Tasmuth T, Sipila R, Kalso E
JAMA . 2014 Jan; 311(1):90-92. PMID: 24381969
No abstract available.
7.
Kaunisto M, Jokela R, Tallgren M, Kambur O, Tikkanen E, Tasmuth T, et al.
Anesthesiology . 2013 Dec; 119(6):1410-21. PMID: 24343286
Background: This article describes the methods and results of the early part (experimental pain tests and postoperative analgesia) of a study that assesses genetic and other factors related to acute...
8.
Kellokumpu-Lehtinen P, Harmenberg U, Joensuu T, McDermott R, Hervonen P, Ginman C, et al.
Lancet Oncol . 2013 Jan; 14(2):117-24. PMID: 23294853
Background: Docetaxel administered every 3 weeks is a standard treatment for castration-resistant advanced prostate cancer. We hypothesised that 2-weekly administration of docetaxel would be better tolerated than 3-weekly docetaxel in...
9.
Leidenius M, Tasmuth T, Jahkola T, Saarto T, Utriainen M, Vaalavirta L, et al.
Duodecim . 2010 Jul; 126(10):1217-25. PMID: 20597351
All forms of breast cancer therapies are associated with both acute adverse effects and manifold long-term morbidity. Due to the common occurrence and favorable prognosis of breast cancer, the number...
10.
Karki A, Anttila H, Tasmuth T, Rautakorpi U
Acta Oncol . 2009 Feb; 48(6):850-9. PMID: 19235573
Background: This study systematically evaluates the effects and harms of physiotherapy methods and explores current treatment practices and costs in relation to lymphoedema in breast cancer patients in Finland. Material...